Adalimumab induction for Crohn's disease

Gastroenterology. 2006 May;130(6):1929. doi: 10.1053/j.gastro.2006.03.051.
No abstract available

Publication types

  • Comment
  • Comparative Study
  • Letter
  • Randomized Controlled Trial

MeSH terms

  • Adalimumab
  • Antibodies, Monoclonal / administration & dosage*
  • Antibodies, Monoclonal, Humanized
  • Crohn Disease / diagnosis*
  • Crohn Disease / drug therapy*
  • Dose-Response Relationship, Drug
  • Drug Administration Schedule
  • Female
  • Humans
  • Male
  • Reference Values
  • Remission Induction*
  • Risk Assessment
  • Severity of Illness Index
  • Treatment Outcome

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Adalimumab